[1] Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis:Framework and proposal of a new classification and case definition[J]. J Periodontol, 2018, 89(Suppl 1):S159-S172. [2] 束蓉, 倪靖. 2018牙周病和植体周病国际新分类:牙周炎分期分级疾病定义系统临床应用体会[J]. 口腔医学, 2020, 40(1):1-6. [3] Sorsa T, Alassiri S, Grigoriadis A,et al. Active MMP-8 (aMMP-8) as a grading and staging biomarker in the periodontitis classification[J]. Diagnostics (Basel), 2020, 10(2):E61. [4] Sorsa T, Gieselmann D, Arweiler NB,et al. A quantitative point-of-care test for periodontal and dental peri-implant diseases[J]. Nat Rev Dis Primers, 2017, 3:17069. [5] Arias-Bujanda N, Regueira-Iglesias A, Balsa-Castro C,et al. Accuracy of single molecular biomarkers in saliva for the diagnosis of periodontitis:A systematic review and meta-analysis[J]. J Clin Periodontol, 2020, 47(1):2-18. [6] Papapanou PN, Susin C. Periodontitis epidemiology:Is periodonti-tis under-recognized, over-diagnosed, or both?[J]. Periodontol 2000, 2017, 75(1):45-51. [7] 胡竹林, 赵诣, 李茵. 口腔龈沟液生物标志物的检测分析现状及临床应用前景展望[J]. 国际口腔医学杂志, 2019, 46(3):308-315. [8] 程兴群, 周学东, 徐欣. 唾液的诊断应用研究[J]. 华西口腔医学杂志, 2016, 34(6):647-653. [9] Kc S, Wang XZ, Gallagher JE. Diagnostic sensitivity and specific-ity of host-derived salivary biomarkers in periodontal disease amongst adults:Systematic review[J]. J Clin Periodontol, 2020, 47(3):289-308. [10] Isola G, Polizzi A, Muraglie S,et al. Assessment of vitamin C and antioxidant profiles in saliva and serum in patients with periodontitis and ischemic heart disease[J]. Nutrients, 2019, 11(12):E2956. [11] Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases[J]. Oral Dis, 2004, 10(6):311-318. [12] Boelen GJ, Boute L, d'Hoop J,et al. Matrix metalloproteinases and inhibitors in dentistry[J]. Clin Oral Investig, 2019, 23(7):2823-2835. [13] Kiili M, Cox SW, Chen HY,et al. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis:Molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue[J]. J Clin Periodontol, 2002, 29(3):224-232. [14] 王亚敏, 张瑞敏. 基质金属蛋白酶作为牙周炎调节因子的研究进展[J]. 口腔医学, 2019, 39(3):271-274. [15] Kuula H, Salo T, Pirilä E,et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis[J]. Infect Immun, 2009, 77(2):850-859. [16] Sorsa T, Tjäderhane L, Konttinen YT,et al. Matrix metalloproteinases:Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation[J]. Ann Med, 2006, 38(5):306-321. [17] Sexton WM, LinY, Kryscio RJ, et al. Salivary biomarkers of periodontal disease in response to treatment[J]. J Clin Periodontol, 2011, 38(5):434-441. [18] Slots J. Periodontitis:facts, fallacies and the future[J]. Periodontol 2000, 2017, 75(1):7-23. [19] Rathnayake N, Gieselmann DR, Heikkinen AM,et al. Salivary diagnostics-point-of-care diagnostics of MMP-8 in dentistry and medicine[J]. Diagnostics (Basel), 2017, 7(1):E7. [20] Sorsa T, Gursoy UK, Nwhator S,et al. Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases[J]. Periodontol 2000, 2016, 70(1):142-163. [21] Sorsa T, Hernández M, Leppilahti J,et al. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods[J]. Oral Dis, 2010, 16(1):39-45. [22] Al-Majid A, Alassiri S, Rathnayake N,et al. Matrix metalloproteinase-8 as an inflammatory and prevention biomarker in periodontal and peri-implant diseases[J]. Int J Dent, 2018, 2018:7891323. [23] de Morais EF, Pinheiro JC, Leite RB,et al. Matrix metalloproteinase-8 levels in periodontal disease patients:A systematic review[J]. J Periodontal Res, 2018, 53(2):156-163. [24] Alassiri S, Parnanen P, Rathnayake N,et al. The ability of quantitative, specific, and sensitive point-of-care/chair-side oral fluid immunotests for aMMP-8 to detect periodontal and peri-implant diseases[J]. Dis Markers, 2018, 2018:1306396. [25] Weng H, Yan Y, Jin YH,et al. Matrix metalloproteinase gene polymorphisms and periodontitis susceptibility:A meta-analysis involving 6, 162 individuals[J]. Sci Rep, 2016, 6:24812. [26] Lira-Junior R, Öztürk VÖ, Emingil G,et al. Salivary and serum markers related to innate immunity in generalized aggressive periodontitis[J]. J Periodontol, 2017, 88(12):1339-1347. [27] Keles Yucel ZP, Afacan B, Emingil G, et al. Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis[J]. J Periodontal Res, 2020, 55(6):887-894. [28] Lee W, Aitken S, Sodek J,et al. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo:Role of active enzyme in human periodontitis[J]. J Periodontal Res, 1995, 30(1):23-33. [29] Al-Tarawneh SK, Border MB, Dibble CF,et al. Defining salivary biomarkers using mass spectrometry-based proteomics:A systematic review[J]. OMICS, 2011, 15(6):353-361. [30] Lorenz K, Keller T, Noack B,et al. Evaluation of a novel point-of-care test for active matrix metalloproteinase-8:Agreement between qualitative and quantitative measurements and relation to periodontal inflammation[J]. J Periodontal Res, 2017, 52(2):277-284. [31] Yuan C, Liu XC, Zheng SG. Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population:An observational study[J]. BMC Oral Health, 2018, 18(1):51. [32] Heikkinen AM, Nwhator SO, Rathnayake N,et al. Pilot study on oral health status as assessed by an active matrix metalloproteinase-8 chairside mouthrinse test in adolescents[J]. J Periodontol, 2016, 87(1):36-40. [33] Schmalz G, Hübscher AE, Angermann H,et al. Associations of chairside salivary aMMP-8 findings with periodontal parameters, potentially periodontal pathogenic bacteria and selected blood parameters in systemically healthy adults[J]. Diagn Microbiol Infect Dis, 2019, 95(2):179-184. [34] Räisänen IT, Sorsa T, Tervahartiala T,et al. Low association between bleeding on probing propensity and the salivary aMMP-8 levels in adolescents with gingivitis and stage I periodontitis[J]. J Periodontal Res, 2021, 56(2):289-297. [35] Heikkinen AM, Räisänen IT, Tervahartiala T,et al. Cross-sectional analysis of risk factors for subclinical periodontitis; active matrix metalloproteinase-8 as a potential indicator in initial periodontitis in adolescents[J]. J Periodontol, 2019, 90(5):484-492. [36] Lang NP, Bartold PM. Periodontal health[J]. J Periodontol, 2018, 89(Suppl 1):S9-S16. [37] Zhang L, Li XE, Yan H,et al. Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis[J]. Medicine, 2018, 97(3):e9642. [38] Izadi Borujeni S, Mayer M, Eickholz P. Activated matrix metalloproteinase-8 in saliva as diagnostic test for periodontal disease? A case-control study[J].Med Microbiol Immunol, 2015, 204(6):665-672. [39] Mauramo M, Ramseier AM, Mauramo E,et al. Associations of oral fluid MMP-8 with periodontitis in Swiss adult subjects[J]. Oral Dis, 2018, 24(3):449-455. [40] Sorsa T, Tjäderhane L, Konttinen YT,et al. Matrix metalloproteinases:Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation[J]. Ann Med, 2006, 38(5):306-321. [41] Kraft-Neumärker M, Lorenz K, Koch R,et al. Full-mouth profile of active MMP-8 in periodontitis patients[J]. J Periodontal Res, 2012, 47(1):121-128. [42] 周蕾, 杨瑞馥. 从定性到定量的转变是 POCT 发展历程中的重要挑战[J]. 中华检验医学杂志, 2014,37(11):801-803. [43] 滕蕊, 贺望虹, 许莹, 等. 基于胶体金免疫层析试纸的牙周炎龈沟液IL-1β体外快速检测方法的研究[J]. 口腔生物医学, 2020, 11(1):46-49. |